CRIS Current Research Information System

DE ROSA, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.710
AS - Asia 1.500
EU - Europa 1.338
AF - Africa 94
SA - Sud America 78
OC - Oceania 4
Totale 4.724
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.685
VN - Vietnam 491
SG - Singapore 381
CN - Cina 359
IT - Italia 336
GB - Regno Unito 285
SE - Svezia 145
DE - Germania 127
FR - Francia 86
IN - India 79
HK - Hong Kong 65
RU - Federazione Russa 63
IE - Irlanda 58
BR - Brasile 53
CH - Svizzera 53
NL - Olanda 43
JP - Giappone 39
ZA - Sudafrica 35
FI - Finlandia 33
UA - Ucraina 30
TG - Togo 29
EE - Estonia 18
BG - Bulgaria 17
JO - Giordania 16
CA - Canada 13
PH - Filippine 13
BE - Belgio 12
AR - Argentina 9
KR - Corea 9
TH - Thailandia 9
PL - Polonia 8
AT - Austria 7
SC - Seychelles 7
CI - Costa d'Avorio 6
IQ - Iraq 6
IR - Iran 6
NG - Nigeria 6
TW - Taiwan 6
VE - Venezuela 6
CL - Cile 5
ID - Indonesia 5
MX - Messico 5
AU - Australia 4
NI - Nicaragua 4
RO - Romania 4
ES - Italia 3
GR - Grecia 3
MY - Malesia 3
BD - Bangladesh 2
CO - Colombia 2
DZ - Algeria 2
EG - Egitto 2
ET - Etiopia 2
KE - Kenya 2
LB - Libano 2
PK - Pakistan 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
AZ - Azerbaigian 1
BO - Bolivia 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DM - Dominica 1
EC - Ecuador 1
HR - Croazia 1
HU - Ungheria 1
KH - Cambogia 1
KZ - Kazakistan 1
LT - Lituania 1
LU - Lussemburgo 1
MA - Marocco 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TR - Turchia 1
UZ - Uzbekistan 1
Totale 4.724
Salva come PNG Salva come JPEG
Città #
Singapore 265
Southend 260
Ashburn 189
Chandler 188
Dong Ket 162
Santa Clara 115
Ho Chi Minh City 98
Fairfield 95
San Jose 87
Hanoi 81
Princeton 72
Wilmington 65
Hong Kong 60
Dublin 58
Houston 54
New York 53
Beijing 51
Bern 49
Ann Arbor 45
Bologna 41
Woodbridge 41
Tokyo 35
Seattle 34
Boardman 30
Rome 30
Helsinki 29
Lauterbourg 29
Lomé 29
Nanjing 28
Westminster 28
Padova 27
Cambridge 26
Milan 25
Jinan 23
Medford 23
Los Angeles 21
Dallas 19
Shenyang 18
Sofia 17
Saint Petersburg 16
Amman 15
Mülheim 14
Turin 14
Berlin 13
Guangzhou 12
San Diego 12
Brussels 11
Da Nang 11
Hebei 11
Buffalo 10
Changsha 10
Jacksonville 10
Ravenna 10
São Paulo 10
Florence 9
Frankfurt am Main 9
Jiaxing 9
Mountain View 9
Pune 9
Shanghai 9
Tianjin 9
Haiphong 8
The Dalles 8
Fremont 7
Redwood City 7
Xi'an 7
Abidjan 6
Bến Tre 6
Nanchang 6
Orem 6
Torino 6
Toronto 6
Warsaw 6
Abeokuta 5
Can Tho 5
Dearborn 5
Johannesburg 5
Kuban 5
Monmouth Junction 5
Mumbai 5
Ninh Bình 5
Norwalk 5
Paris 5
Phoenix 5
Redondo Beach 5
Rio de Janeiro 5
Taizhou 5
Ardabil 4
Bari 4
Falls Church 4
Lanzhou 4
Managua 4
Ningbo 4
Taiyuan 4
Turku 4
Wuhan 4
Bangkok 3
Biên Hòa 3
Brooklyn 3
Castelfranco Emilia 3
Totale 3.039
Salva come PNG Salva come JPEG
Nome #
Follow-up del cancro del pancreas esocrino 451
Adjuvant systemic chemotherapy after putative curative resection of colorectal liver and lung metastases. 254
Antiprotease strategy in pancreatic cancer treatment: emergence from a preclinical study. 248
Antitumoral efficacy of the protease inhibitor gabexate mesilate in colon cancer cells harbouring KRAS, BRAF and PIK3CA mutations 246
Asbestos: a putative risk factor for intrahepatic cholangiocarcinoma 209
Second surgery or chemotherapy for relapse after radical resection of colorectal cancer metastases. 208
Second-line chemotherapy in patients with biliary tract cancer. 178
Metronomic capecitabine in advanced hepatocellular carcinoma patients:a phase II study. 166
EXPOSURE TO ASBESTOS: A PUTATIVE UNKNOWN RISK FACTOR FOR INTRAHEPATIC CHOLANGIOCARCINOMA 164
KRAS and BRAF mutational status as selective criteria for targeted therapy in cholangiocarcinoma. 163
The Protease Inhibitor Gabexate Mesylate Reduces Invasiveness and Angiogenesis in Pancreatic Cancer Cell Lines, Enhancing Gemcitabine Action 161
Impact of adjuvant chemotherapy on time to relapse in cholangiocarcinoma. 159
High prevalence of asbestos exposure in bile duct cancer patients 157
The follow-up issues: from the necessity to the opportunity 151
Second-line chemotherapy in biliary tract cancer patients. 147
Role of adjuvant chemoradiotherapy (CRT) and chemotherapy alone in pancreatic cancer: experience in 25 patients. 146
High-resolution genomic profiling of Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) patients identified novel recurrent copy number variations involved in both pathogenesis and resistance to tyrosine kinase inhibitors 145
Effect of the serine proteases inhibitor gabexate mesylate (GM) on the activity of gemcitabine (G) in cell lines of pancreatic cancer (PC) 145
Feasibility of triplets (5-FU, oxaliplatin and irinotecan based) in front and subsequent lines of metastatic colorectal cancer patients. 143
Metronomic capecitabine as second-line treatment after sorafenib for hepatocelllular carcinoma. 140
Clinical safety and efficacy of adjuvant chemotherapy in radically resected cholangiocarcinoma patients. 139
Genome wide analysis of Philadelphia positive (Ph+) acute lymphoblastic leukemia (ALL) reveals a recurring deletion of VPREB1 gene which affects B-cell differentiation 137
Irinotecan toxicity: genes or intestinal microflora? 136
Metronomic capecitabine in advanced hepatocellualr cacinoma patients who have failed sorafenib: a phase II study 131
Metronomic capecitabine as second-line treatment for patients with hepatocellular carcinoma with preserved liver function: A phase II study. 128
METRONOMIC CAPECITABINE IN HEPATOCELLULAR CARCINOMA RELAPSE AFTER LIVER TRANSPLANTATION: A RETROSPECTIVE STUDY 121
IMPACT OF MULTIDISCIPLINARY APPROACH ON SURVIVAL OF PATIENTS WITH KLATSKIN TUMOR 121
Intestinal microbiota around colorectal cancer genesis 115
Totale 4.809
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.648
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.648
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021182 0 0 0 0 0 0 0 0 0 7 7 168
2021/2022586 63 32 20 29 54 35 18 35 17 37 144 102
2022/2023750 85 111 39 89 44 54 10 47 114 22 75 60
2023/2024254 27 28 2 22 12 88 16 8 5 11 19 16
2024/2025666 35 88 59 63 156 28 39 33 14 43 19 89
2025/20261.392 159 72 102 109 184 73 120 59 405 109 0 0
Totale 4.809